AU594486B2 - Purified fetal thymidine kinase - Google Patents

Purified fetal thymidine kinase

Info

Publication number
AU594486B2
AU594486B2 AU76075/87A AU7607587A AU594486B2 AU 594486 B2 AU594486 B2 AU 594486B2 AU 76075/87 A AU76075/87 A AU 76075/87A AU 7607587 A AU7607587 A AU 7607587A AU 594486 B2 AU594486 B2 AU 594486B2
Authority
AU
Australia
Prior art keywords
purified
thymidine kinase
thymidine
purified fetal
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU76075/87A
Other versions
AU7607587A (en
Inventor
Pierre Nicolas Jouan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Debat SA
Original Assignee
Laboratoire Debat SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Debat SA filed Critical Laboratoire Debat SA
Publication of AU7607587A publication Critical patent/AU7607587A/en
Application granted granted Critical
Publication of AU594486B2 publication Critical patent/AU594486B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C12N9/1211—Thymidine kinase (2.7.1.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

The invention relates to purified thymidine kinase of foetal type (abbreviated to TK-F) as a new industrial product. It also relates to the process for preparing the purified TK-F by a process which comprises coupling the TK-F with thymidine and then cleaving the resulting TK-F-thymidine complex. The purified TK-F according to the invention can be used in the preparation of antiTK-F antibody to be involved especially as a reagent in the field of dosages and as a medication in therapeutics.
AU76075/87A 1986-07-31 1987-07-24 Purified fetal thymidine kinase Ceased AU594486B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8611101 1986-07-31
FR8611101A FR2602242B1 (en) 1986-07-31 1986-07-31 THYMIDINE KINASE PURIFIED FETAL TYPE

Publications (2)

Publication Number Publication Date
AU7607587A AU7607587A (en) 1988-02-04
AU594486B2 true AU594486B2 (en) 1990-03-08

Family

ID=9337917

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76075/87A Ceased AU594486B2 (en) 1986-07-31 1987-07-24 Purified fetal thymidine kinase

Country Status (14)

Country Link
EP (1) EP0255431B1 (en)
JP (1) JPS6359886A (en)
CN (1) CN87105215A (en)
AT (1) ATE68821T1 (en)
AU (1) AU594486B2 (en)
DE (1) DE3774025D1 (en)
DK (1) DK387387A (en)
ES (1) ES2038681T3 (en)
FR (1) FR2602242B1 (en)
GR (1) GR3003416T3 (en)
IE (1) IE61237B1 (en)
NZ (1) NZ221246A (en)
PT (1) PT85406B (en)
ZA (1) ZA875378B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995004758A1 (en) * 1993-08-06 1995-02-16 Brigham Young University Technology Transfer Office Monoclonal antibodies to thymidine kinase isozymes
SE9401380D0 (en) * 1994-04-22 1994-04-22 Sven Skog New cell growth-related peptide and its use
CN1301821A (en) * 1999-12-27 2001-07-04 上海博德基因开发有限公司 New polypeptide-thymidylate kinase 11 and polynucleotide coding such polypeptide
US7311906B2 (en) 2004-04-30 2007-12-25 Brigham Young University Anti-viral activity of an anti-thymidine kinase monoclonal antibody
US8551486B2 (en) 2004-05-21 2013-10-08 Savoy Pharmaceuticals, Inc. Monoclonal antibodies to human thymidine kinase to treat cancer
US7837998B2 (en) 2004-05-21 2010-11-23 Nathaniel Lallatin Anti-cancer activity of an anti-thymidine kinase monoclonal antibody
WO2011082345A2 (en) 2009-12-30 2011-07-07 Brigham Young University Compositions and methods for cancer management using antibodies binding to nucleotide salvage pathway enzymes and complexes thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2028588A1 (en) * 1970-06-10 1971-12-16 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Method of Obtaining Thymidine Kinase

Also Published As

Publication number Publication date
JPH0438392B2 (en) 1992-06-24
NZ221246A (en) 1991-05-28
IE61237B1 (en) 1994-10-19
CN87105215A (en) 1988-02-24
GR3003416T3 (en) 1993-02-17
PT85406A (en) 1987-08-01
AU7607587A (en) 1988-02-04
FR2602242A1 (en) 1988-02-05
DK387387A (en) 1988-02-01
PT85406B (en) 1990-04-30
EP0255431A1 (en) 1988-02-03
DK387387D0 (en) 1987-07-24
IE872064L (en) 1988-01-31
ES2038681T3 (en) 1993-08-01
ATE68821T1 (en) 1991-11-15
DE3774025D1 (en) 1991-11-28
JPS6359886A (en) 1988-03-15
ZA875378B (en) 1988-01-29
FR2602242B1 (en) 1989-05-26
EP0255431B1 (en) 1991-10-23

Similar Documents

Publication Publication Date Title
AU543679B2 (en) Oligo saccharidic fractions and oligo saccharides having biological properties, preparation process thereof and applications thereof as medicaments
BR9106140A (en) MIXTURE OF REACTION FOR OLEFINE OXIDATION IN CARBONILLA PRODUCT, WACKER PROCESS FOR THE MANUFACTURE OF ACETALDEHYD BY ETHYLENE OXIDATION, PROCESS FOR OLEIDIN OXIDATION IN CARBONILLA PRODUCT AND VANIUM (VANIO) (VADIO) OXIDATION
IL81669A (en) Aryl-substituted(n-piperidinyl)methyl-and(n-piperazinyl)-methylazoles,their preparation and pharmaceutical compositions containing them
AU588837B2 (en) Polypeptide
AU594486B2 (en) Purified fetal thymidine kinase
AU5957790A (en) Improvements related to techniques for the amplification of nucleic acid
HU905304D0 (en) Process for producing disubstituted (quinoline-2-il-methoxy)-phenyl-acetic acid derivatives and pharmaceutical preparatives containing them
AU2765788A (en) Process for the catalytic hydration of olefins
AU6397490A (en) Integrated process for the production of diisopropyl ether and gasoline
DE3576686D1 (en) CHINOLINONES, PROCESS FOR THEIR PRODUCTION AND THE PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME.
PT87309A (en) PROCESS FOR THE PREPARATION OF BENZAZEPINE BY PRODUCTS
PT87503A (en) PROCESS FOR THE PREPARATION OF NEW CATHECOLAMINE BY PRODUCTS
PT92726A (en) PROCESS FOR THE ELIMINATION OF ETHANOL FROM DRINKS PRODUCED BY FERMENTATION
AU2765488A (en) Process for the catalytic hydration of olefins
DE3851618D1 (en) Process for the preparation of alkylarsine compounds.
TR23494A (en) FERROCHROME PRODUCTION PROCESS
AU568694B2 (en) N-benzyl-n-phenyl-b-pyrrolidinyl-f-isobutoxy-propylamine
AU7391091A (en) Process for the conversion of light olefins to ether-rich gasoline
DK0560029T3 (en) Process for the preparation of alkylarsine compounds
IL59539A0 (en) Industrial production of an antigen of herpes simplex virus
RU1830068C (en) Process for d-6-fluoro-2,3-dihydro-2ъ,5ъ-dioxospiro 4-h-1-benzopyrane-4,4ъ-imidazolidine)-2-carboxamide
IL79285A0 (en) Process for the valorization,in the form of perbrominated products,of underbrominated products produced as solutions
EP0287007A3 (en) Process for cleaving aliphatic ether compounds
ATE40380T1 (en) ANTHRACYCLINE COMPOUND, PROCESS FOR THEIR PRODUCTION, ITS PHARMACEUTICAL COMPOSITION AND ITS USE AS A MEDICINAL PRODUCT.
AU1555088A (en) Process for the preparation of sialon products